medigraphic.com

2012, Number 4

<< Back Next >>

Anales de Radiología México 2012; 11 (4)

Neuroimaging of cognitive impairment

Boleaga-Durán B, Patiño IF, Vázquez FV, Chuc M

Language: Spanish
References: 14
Page: 191-199
PDF size: 455.32 Kb.


ABSTRACT

Mild cognitive impairment (MCI) is defined as the transitional state between the cognitive changes of normal aging and early onset dementia. Recently increased efforts have been made to identify the clinical characteristics of MCI due to interest in identifying the characteristics of dementia disorders such as Alzheimer’s Disease (AD). Because MCI represents the earliest stage of such diseases, its clinical, epidemiological, neuroimaging, and neuropathological study is of interest.


REFERENCES

  1. López-Pousa S. La demencia: concepto y epidemiología. En: Alberca R, López-Pousa. Enfermedad de Azheimer y otras demencias. Ed. Médica Panamericana. 3.ª edición. Madrid 2006. p 36.

  2. Petersen RC, Negash S. Mild cognitive impairment: An overview. CNS Spectr. 2008;13(1):45-53.

  3. Petersen RC, Roberts RO, Knopman DS. Mild cognitive impairment: Ten years later. Arch Neurol 2009;66(12):1447-1455.

  4. Winblad B, Palmer K. Mild cognitive impairment–beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment. J Intern Med 2004;256(3):240-246.

  5. Fox NC. Correlation between rates of brain atrophy and cognitive decline in AD. Neurology 1999;52(8):1687-1689.

  6. Killiany RJ. Use of structural magnetic resonance imaging to predict who will get Alzheimer´s disease. Ann Neurol 2000;47(4):430-439.

  7. Müller MJ, Greverus D. Functional implications of hippocampal volume and difusitvity in mild cognitive impairment. Neuroimage 2005;28:1033-1042.

  8. Hachinski V. Leuko-Araiosis. Arch Neurol 1987;44:21-23.

  9. Yoshita M, Fletcher E. Extent and distribution of white matter hyperintensities in normal aging, MCK and AD. Neurology 2006;67:2192-2198.

  10. Petrella J, et al. Radiology 2003;226:315-336.

  11. Jagust WJ. Landau. Relationships between biomarkers in aging and dementia. Neurology 2009;73(15):1193-1199.

  12. Silverman DH, Small GW, Chang CY, et al. Positron emission tomogrphy in evaluation of dementia: Regional brain metabolism and long –term outcome. JAMA 2001;286:2120-2127.

  13. Nestor PJ, Fryer TD, Smielewski P, Hodges JR. Lymbic hypometabolism in Alzheimer´s disease and mild cognitive impairment. Ann Neurol 2003;54:343-351.

  14. American College of Radiology. ACR Appropriateness Criteria. Expert Panel on Neurologic Imaging at http://www.acr.org




2020     |     www.medigraphic.com